Global DNA Hypomethylation

Global DNA Hypomethylation is a widespread reduction in the overall level of cytosine methylation across the genome of a cancer cell, most prominently affecting repetitive DNA elements and intergenic regions, and representing one of the earliest and most consistently observed epigenetic abnormalities across nearly all cancer types.

Normal DNA Methylation Patterns

Distribution in Healthy Cells

In normal cells, the majority of cytosine bases within the dinucleotide sequence formed by cytosine followed by guanine, referred to as CpG sites, are methylated, particularly within repetitive sequences, transposable elements, and the bodies of actively transcribed genes. In contrast, CpG islands located near gene promoters typically remain unmethylated, allowing normal gene expression to proceed.

Functional Roles of Methylation

Methylation of repetitive elements and transposable sequences normally helps maintain their transcriptional silence, preventing these mobile genetic elements from being expressed and potentially inserting themselves into new genomic locations, which could otherwise disrupt gene function or genome stability.

Characteristics of Hypomethylation in Cancer

Repetitive Element Demethylation

A major component of global hypomethylation involves loss of methylation at repetitive DNA sequences, including long interspersed nuclear elements and other transposable element families, which are normally kept transcriptionally silent through dense methylation in healthy tissue.

Intergenic and Gene Body Changes

Hypomethylation in cancer extends beyond repetitive elements to affect intergenic regions and the bodies of genes, contributing to a broadly altered methylation landscape that differs substantially from the pattern observed in the corresponding normal tissue.

Progressive Loss During Tumor Development

Global hypomethylation often becomes more pronounced as a tumor advances, with more aggressive and later-stage tumors frequently displaying lower overall methylation levels than earlier-stage lesions of the same type.

Mechanisms and Consequences

Genomic Instability

Loss of methylation at repetitive and centromeric regions is associated with increased chromosomal instability, since proper methylation of these regions normally contributes to maintaining correct chromosome segregation and structural integrity during cell division.

Reactivation of Transposable Elements

Demethylation can reactivate normally silenced transposable elements, allowing them to become transcriptionally active and, in some cases, to mobilize within the genome, potentially causing insertional mutagenesis that disrupts additional genes.

Loss of Imprinting

Hypomethylation can disrupt genomic imprinting, the normal process by which certain genes are expressed exclusively from either the maternally or paternally inherited copy, leading to abnormal biallelic expression or silencing of imprinted genes involved in growth regulation.

Altered Chromatin Structure

Because methylation status influences the broader chromatin environment, widespread hypomethylation contributes to a more open and permissive chromatin state in affected regions, which can have downstream effects on the expression of nearby genes and on overall genome organization within the nucleus.

Relationship to Promoter Hypermethylation

Global hypomethylation typically occurs alongside a seemingly contradictory pattern in which specific gene promoters, particularly those regulating tumor suppressor genes, become locally hypermethylated and silenced. This combination of global loss of methylation with focal gain of methylation at specific promoters illustrates that cancer epigenomes are not simply "more" or "less" methylated overall, but rather redistributed in a manner that favors malignant behavior.

Detection and Assessment

Genome-Wide Methylation Profiling

Techniques capable of measuring methylation status across the genome, including bisulfite-based sequencing approaches and methylation microarrays, allow researchers to quantify overall methylation levels and to map which specific genomic regions have lost methylation in a given tumor sample.

Repetitive Element Assays

Because repetitive elements make up a substantial fraction of the genome, methylation levels at representative repetitive sequences are sometimes used as a practical surrogate measure for estimating global methylation status without requiring comprehensive genome-wide profiling.

Biological and Clinical Significance

Global DNA hypomethylation is considered an early and consistent hallmark of malignant transformation across diverse tumor types, contributing to genomic instability, transposable element reactivation, and loss of normal gene regulation. Its consistent presence across cancer types has made it a subject of interest both as a potential biomarker of malignant transformation and as a feature that may be modifiable through therapies targeting the enzymes responsible for establishing and maintaining DNA methylation patterns.